<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font7" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="110" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Nuclear Receptor 2005, 3 :1<i>Nuclear Receptor</i></text>
<text top="41" left="370" width="184" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.nuclear-receptor.com/content/3/1/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="105" segment_no="12" tag_type="text">Page 2 of 11<b>3</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="106" segment_no="13" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="3" tag_type="text">perturbations of the hypothalamic-pituitary-thyroid hor-</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="text">mone endocrine axis. The peripheral thyroid hormone</text>
<text top="110" left="55" width="224" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="3" tag_type="text">metabolism is also altered in patients with CRF [5-9].<i>(page number not for citation purposes)</i></text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="text">In uremia various thyroid hormone physiological charac-</text>
<text top="145" left="55" width="241" height="11" font="font4" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">teristics are altered. Total and free tyroxine (T 4 ) and 3,5,3'-</text>
<text top="157" left="55" width="241" height="11" font="font4" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">triiodothyronine (T 3 ) levels in the serum are frequently<a href=""> CRF [5-9].</a></text>
<text top="169" left="55" width="241" height="10" font="font4" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">reduced in patients with CRF [10,11]. Reduced T 3 levels</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">might be explained by decreased peripheral tissue conver-</text>
<text top="192" left="55" width="241" height="11" font="font4" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">sion of T 4 to T 3 [12]. Most CRF patients, however, are con-</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">sidered to be euthyroid as evidenced by normal thyroid-</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">stimulating hormone (TSH) levels [11,13]. In addition,</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">the prevalence of thyroid diseases, including goiter and</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">hypothyroidism, are also higher in CRF patients than in</text>
<text top="251" left="55" width="119" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">the general population [10].<a href="">duced in patients with CRF [10,11</a>]. Reduced T</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="5" tag_type="text">Thyroid hormones control numerous aspects of mamma-</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="5" tag_type="text">lian development and metabolism, of which most of</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="5" tag_type="text">these actions are mediated by specific thyroid hormone</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="5" tag_type="text">receptors (TRs). An important metabolic activity of thy-</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="5" tag_type="text">roid hormones is to increase oxygen consumption of tar-</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="5" tag_type="text">get tissues [14,15]. In fact, in experimental renal failure</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="5" tag_type="text">and in uremic patients the expected increase in basal oxy-</text>
<text top="357" left="55" width="241" height="10" font="font4" id="p1_t26" reading_order_no="23" segment_no="5" tag_type="text">gen consumption following the administration of T 3 is<a href="">[12]</a>. Most CRF patients, however, are con-</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="5" tag_type="text">not observed, suggesting that CRF is associated with resist-</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="5" tag_type="text">ance to thyroid hormone action [16-18]. However, it is<a href="">vels [11,13]. </a>In addition,</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="5" tag_type="text">currently not known whether thyroid hormone receptors</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="5" tag_type="text">play a role in the thyroid dysfunction observed in uremic</text>
<text top="416" left="55" width="36" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="5" tag_type="text">patients.<a href="">n [10].</a></text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="9" tag_type="text">TRs are ligand-regulated transcription factors of the</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="9" tag_type="text">nuclear receptor superfamily which includes steroid hor-</text>
<text top="460" left="55" width="241" height="13" font="font4" id="p1_t34" reading_order_no="31" segment_no="9" tag_type="text">Î³ mones and vitamin D receptors and also PPAR</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="9" tag_type="text">[15,19,20]. TRs modulate gene expression by binding spe-</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="9" tag_type="text">cific DNA sequences, known as thyroid response elements</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="9" tag_type="text">(TREs), found in the promoters of TR-regulated genes.<a href="">[14,15]. In fact, in</a> experimental renal failure</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="9" tag_type="text">TREs are composed of repeats of the consensus half-site</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="9" tag_type="text">AGGTCA in a variety of different orientations, including</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="9" tag_type="text">direct repeats spaced by four nucleotides (DR-4), inverted</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="9" tag_type="text">palindromes (F2) and palindromes [21,22]. In the pres-</text>
<text top="557" left="55" width="241" height="10" font="font4" id="p1_t42" reading_order_no="39" segment_no="9" tag_type="text">ence of T 3 , TRs preferentially form heterodimers with the</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="9" tag_type="text">retinoid X receptors (RXRs) although unliganded TR<a href=""> action [16-18</a>]. However, it is</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="9" tag_type="text">binds to DNA as either homodimers or monomers</text>
<text top="592" left="55" width="34" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="9" tag_type="text">[20,23].</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="10" tag_type="text">In recent years, it has become apparent that uremic toxins</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="10" tag_type="text">can impair the function of some nuclear receptors, such as</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="10" tag_type="text">the vitamin D receptor (VDR). Previous studies suggest</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="10" tag_type="text">that uremic toxins inhibit the binding of VDR to DNA and</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="10" tag_type="text">can contribute to the vitamin D resistance observed in</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="10" tag_type="text">CRF patients [24-28]. It is, therefore, conceivable that ure-<a href="">15,19,20</a>]. TRs modulate gene expression by binding spe-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="10" tag_type="text">mia also induces modifications in thyroid hormone</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="10" tag_type="text">receptors and consequently plays a role in the thyroid hor-</text>
<text top="709" left="55" width="199" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="10" tag_type="text">mone dysfunction observed in uremic patients.</text>
<text top="84" left="313" width="241" height="13" font="font4" id="p1_t55" reading_order_no="52" segment_no="2" tag_type="text">We investigated the effects of uremia on TR Î² 1 function by</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="2" tag_type="text">studying the ability of TRs to bind to DNA sequences in</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="2" tag_type="text">the presence or absence of uremic plasma collected from<a href="">[21,22</a>]. In the pres-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="2" tag_type="text">CRF patients. Our results showed that uremic plasma sig-</text>
<text top="131" left="313" width="242" height="13" font="font4" id="p1_t59" reading_order_no="56" segment_no="2" tag_type="text">nificantly reduced the binding of TR heterodimers (TR Î² 1-</text>
<text top="142" left="313" width="241" height="13" font="font4" id="p1_t60" reading_order_no="57" segment_no="2" tag_type="text">RXR Î± ), but not of homodimers (TR Î² 1-TR Î² 1) to DR-4.</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="2" tag_type="text">Furthermore, uremic plasma also inhibited the binding of</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="2" tag_type="text">a VDR heterodimer (VDR-RXR) to DR-3, while the bind-</text>
<text top="178" left="313" width="241" height="13" font="font4" id="p1_t63" reading_order_no="60" segment_no="2" tag_type="text">ing of PPAR Î³ to DR-1 remained unaltered. Moreover,<a href="">20,23]</a>.</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="2" tag_type="text">hemodialysis (HD) diminished the inhibitory effect of</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="2" tag_type="text">CRF patients' plasma on the binding of both TR and VDR</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="2" tag_type="text">heterodimers to DNA. When human promonocyte cells</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="2" tag_type="text">were incubated with ultrafiltrate collected Pre-HD the</text>
<text top="239" left="313" width="241" height="11" font="font4" id="p1_t68" reading_order_no="65" segment_no="2" tag_type="text">transcriptional activation induced by T 3 was inhibited.</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="2" tag_type="text">This inhibition was lost when the cells were treated with<a href="">tients [24-28]. It </a>is, therefore, conceivable that ure-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="2" tag_type="text">ultrafiltrate collected after-HD. Thus, we suggest that dia-</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="2" tag_type="text">lyzable uremic toxins selectively block the binding of</text>
<text top="283" left="313" width="241" height="13" font="font4" id="p1_t72" reading_order_no="69" segment_no="2" tag_type="text">TR Î² 1-RXR Î± and VDR-RXR heterodimers to DNA and</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="2" tag_type="text">reduce the transcriptional activities regulated by these</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="2" tag_type="text">receptors. These results indicate that the thyroid hormone</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="2" tag_type="text">dysfunction observed in uremia may be partially</text>
<text top="330" left="313" width="241" height="14" font="font4" id="p1_t76" reading_order_no="73" segment_no="2" tag_type="text">explained by T 3 resistance induced by impaired TR Î² 1</text>
<text top="345" left="313" width="38" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="2" tag_type="text">function.</text>
<text top="369" left="313" width="36" height="10" font="font7" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="title">Results</text>
<text top="377" left="313" width="235" height="13" font="font6" id="p1_t79" reading_order_no="76" segment_no="7" tag_type="title">Uremic plasma inhibits the binding of hTR Î² 1-hRXR Î± on</text>
<text top="392" left="313" width="22" height="9" font="font8" id="p1_t80" reading_order_no="77" segment_no="7" tag_type="title">DR-4</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="8" tag_type="text">To study the effects of uremic plasma on the ability of</text>
<text top="413" left="313" width="241" height="13" font="font4" id="p1_t82" reading_order_no="79" segment_no="8" tag_type="text">TR Î² 1 to bind to a specific TRE we analyzed the binding of</text>
<text top="424" left="313" width="241" height="13" font="font4" id="p1_t83" reading_order_no="80" segment_no="8" tag_type="text">hRXR Î± -hTR Î² 1 heterodimers to DR-4. In this assay, the</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="8" tag_type="text">protein-DNA complex was visualized by labeling the</text>
<text top="448" left="313" width="241" height="13" font="font4" id="p1_t85" reading_order_no="82" segment_no="8" tag_type="text">TR Î² 1 with 35 S. In the presence of T 3 , the addition of</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="8" tag_type="text">increasing amounts (Figure 1; lanes 2â4) of plasma from</text>
<text top="471" left="313" width="241" height="13" font="font4" id="p1_t87" reading_order_no="84" segment_no="8" tag_type="text">normal individuals improved the binding of hRXR Î± -</text>
<text top="483" left="313" width="241" height="13" font="font4" id="p1_t88" reading_order_no="85" segment_no="8" tag_type="text">hTR Î² 1 to DNA. Conversely, TR incubation with uremic</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="8" tag_type="text">plasma (lanes 5â7) collected prior to hemodialysis signif-</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="8" tag_type="text">icantly reduced the binding of heterodimers (RXR-TR) to</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="8" tag_type="text">DR-4. Band densitometry analysis of 5 independent</text>
<text top="530" left="313" width="241" height="13" font="font4" id="p1_t92" reading_order_no="89" segment_no="8" tag_type="text">experiments showed that uremic plasma reduced hRXR Î± -</text>
<text top="542" left="313" width="241" height="13" font="font4" id="p1_t93" reading_order_no="90" segment_no="8" tag_type="text">hTR Î² 1-DR-4 complex formation by 77 Â± 15%, compared</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="8" tag_type="text">to plasma from normal subject (not shown). Similar</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="8" tag_type="text">results were observed for the thyroid response element F2</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="8" tag_type="text">(inverted palindrome) in which uremic plasma also</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="8" tag_type="text">inhibited the RXR-TR binding to DNA (not shown). Pre-</text>
<text top="601" left="313" width="241" height="13" font="font4" id="p1_t98" reading_order_no="95" segment_no="8" tag_type="text">treatment of hTR Î² 1 with T 3 failed to improve the ability of</text>
<text top="612" left="313" width="175" height="13" font="font4" id="p1_t99" reading_order_no="96" segment_no="8" tag_type="text">the dimer hRXR Î± -hTR Î² 1 to bind to DNA.</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="11" tag_type="text">We used uremic plasma from four different patients to</text>
<text top="648" left="313" width="241" height="13" font="font4" id="p1_t101" reading_order_no="98" segment_no="11" tag_type="text">determine whether the observed inhibition of RXR Î± -TR Î² 1</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="11" tag_type="text">binding to DNA (DR-4) was patient specific. Uremic</text>
<text top="671" left="313" width="241" height="13" font="font4" id="p1_t103" reading_order_no="100" segment_no="11" tag_type="text">plasma samples from all four patients inhibited RXR Î± -</text>
<text top="683" left="313" width="241" height="13" font="font4" id="p1_t104" reading_order_no="101" segment_no="11" tag_type="text">TR Î² 1 binding to DR-4 to various degrees (not shown).</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="11" tag_type="text">However, we could not detect any correlation between TR</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="11" tag_type="text">binding impairment and abnormalities in plasma levels</text>
<text top="721" left="313" width="165" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="11" tag_type="text">of urea, creatinine or thyroid hormone.</text>
</page>
</pdf2xml>
